In Situ Hybridization (ISH): Probe Design, Controls, and Readout

In situ hybridization (ISH) detects a specific DNA or RNA sequence directly inside intact cells or tissue sections by hybridizing it to a labeled, complementary nucleic-acid probe. Because the target is never extracted, ISH preserves spatial information that extraction-based methods (Northern/Southern blot, RT-PCR, RNA-seq) discard entirely — it answers not just whether a sequence is present, but exactly which cells or subcellular compartments express it.

The Core Principle

ISH relies on Watson-Crick base pairing between a labeled probe and its complementary target sequence, carried out on fixed cells or tissue sections rather than on material purified in a tube. The workflow follows a common backbone regardless of the specific probe chemistry used:

• Fixation and permeabilization — tissue is fixed (commonly with paraformaldehyde) to cross-link and immobilize nucleic acids in place, then permeabilized enough to let the probe reach its target without destroying tissue morphology.
• Prehybridization — a blocking step that reduces nonspecific probe binding, analogous to blocking in a Western blot.
• Hybridization — the labeled probe is applied under conditions (temperature, salt, formamide concentration) that favor specific, high-affinity binding to its exact complementary sequence while minimizing mismatched binding elsewhere in the tissue.
• Stringency washes — a series of washes at defined temperature and salt concentration remove probe that bound nonspecifically or with mismatches, leaving only correctly hybridized probe behind.
• Detection — the bound, labeled probe is visualized, producing a signal localized to the exact cells, and often the exact subcellular region, where the target sequence is present.

The technique is used for both DNA targets (e.g., localizing a gene or chromosomal region — often called FISH when the label is fluorescent) and RNA targets (localizing gene expression by detecting mRNA transcripts directly in tissue, the more common research use today). Because it works on intact, fixation-sensitive tissue rather than extracted lysate, ISH is typically performed on unfixed cryosections or on formalin-fixed paraffin-embedded (FFPE) sections, depending on probe chemistry and target stability — see CASRAI’s cryostat guide for how frozen sectioning supports fixation-sensitive protocols like this one.

Probe Design

Probe design decisions drive both sensitivity and specificity, and researchers weigh three main variables:

• Probe length. Longer probes (several hundred bases, typical of riboprobes transcribed in vitro) generally give stronger signal per hybridization event but tolerate less mismatch and can have more trouble penetrating dense tissue. Shorter oligonucleotide probes (tens of bases) penetrate more readily and can be pooled — multiple short probes tiled across a transcript, as used in branched-DNA and related high-sensitivity chemistries — to recover sensitivity that a single short probe would lack.
• GC content. GC content sets the probe’s melting temperature (Tm) and therefore the hybridization and wash temperatures needed for specific binding: probes with unusually high or low GC content relative to the rest of the sequence require adjusted stringency conditions, and regions with extreme GC content or repetitive sequence are generally avoided in probe design to limit cross-hybridization.
• Labeling chemistry. Three labeling approaches are standard:
  • Digoxigenin (DIG) labeling — the probe incorporates DIG-conjugated nucleotides and is detected indirectly with an anti-DIG antibody conjugated to an enzyme (commonly alkaline phosphatase), which then drives a chromogenic or fluorescent substrate reaction. DIG-ISH is non-radioactive, has good shelf life, and remains one of the most widely used chemistries for chromogenic detection.
  • Direct fluorescent labeling — the probe itself carries a fluorophore (or a hapten detected with a fluorophore-conjugated antibody), read out by fluorescence microscopy. This is the basis of FISH and enables multiplexing — several probes with spectrally distinct fluorophores detected simultaneously in the same tissue section.
  • Radioactive labeling — probes labeled with a radioisotope (historically ³⁵S or ³H) detected by autoradiography. This was the original ISH detection chemistry and offers high sensitivity, but its long exposure times, radiation-safety burden, and poorer spatial resolution compared to non-isotopic methods have made it largely legacy in routine practice, retained mainly where its quantitative signal properties are specifically needed.

Essential Controls

Because ISH signal depends on correct hybridization rather than a simple presence/absence readout, controls are what separate real signal from artifact, and a standard experiment includes at least these two:

• Sense-strand negative control. For RNA ISH, a probe complementary to the sense strand (i.e., matching rather than complementary to the target mRNA) is applied to a serial or adjacent section under identical conditions. Because the sense probe cannot hybridize to the mRNA target, any signal it produces reflects nonspecific binding, autofluorescence, or endogenous background — not true target detection — and sets the baseline the antisense (true) probe’s signal must clearly exceed.
• Positive control tissue. A tissue or cell sample with well-established, independently confirmed expression of the target sequence is run in parallel to confirm the hybridization and detection chemistry are working end-to-end. A negative result in experimental tissue is uninterpretable without a positive control showing the assay itself was functional that day.

Additional controls commonly paired with these two include an RNase-pretreatment control (RNase digestion before hybridization should abolish RNA-target signal) and a housekeeping-gene probe to confirm tissue RNA integrity, though the sense-strand and positive-tissue controls are the two considered essential in any properly controlled ISH run.

Readout Methods

How bound probe is visualized determines both what equipment is needed and what the resulting image can show:

• Chromogenic detection pairs an enzyme-conjugated antibody (commonly alkaline phosphatase with NBT/BCIP, or horseradish peroxidase with DAB) against the probe’s hapten label with a substrate that deposits a permanent, visible precipitate at the site of hybridization. The result is read on a standard brightfield microscope, integrates naturally with routine histology counterstains (e.g., hematoxylin), and produces a durable, archivable slide — the standard choice in diagnostic and many core-facility settings.
• Fluorescent detection reads the probe’s fluorophore (direct or antibody-mediated) on a fluorescence or confocal microscope. It supports multiplexing several targets at once via spectrally distinct fluorophores, gives better quantitative and subcellular resolution, but the signal photobleaches over time and requires fluorescence imaging equipment rather than a standard brightfield scope.
• High-sensitivity branched-DNA variants (e.g., RNAscope). Newer single-molecule RNA ISH platforms use pairs of short “Z-probes” that must bind adjacent, correctly matched sites before a branched signal-amplification scaffold can assemble, then amplify each bound probe pair through sequential preamplifier/amplifier hybridization before label deposition. This double-Z requirement plus amplification substantially improves both specificity (a single mismatched half-probe generates no signal) and sensitivity (down to single-transcript detection) compared with conventional single-probe ISH, at the cost of a more expensive, proprietary reagent kit and workflow. RNAscope is the best-known commercial implementation of this branched-DNA amplification approach as of this writing.

Frequently Asked Questions

What is the difference between ISH and FISH?

FISH (fluorescence in situ hybridization) is a subtype of ISH that specifically uses fluorescent labeling and fluorescence microscopy for readout. “ISH” is the umbrella term covering any labeled-probe hybridization performed in intact cells or tissue, including chromogenic (DIG-based) and, historically, radioactive detection as well.

Can ISH detect both DNA and RNA targets?

Yes. DNA ISH localizes genomic sequences (a gene, a chromosomal region, or a translocation breakpoint), while RNA ISH localizes gene expression by detecting mRNA (or other RNA species) directly in tissue. RNA ISH is the more common research application because it shows where and how strongly a gene is actually expressed, not just where its genomic locus sits.

Why is a sense-strand control necessary if a “no-probe” control seems simpler?

A no-probe control only rules out signal from the detection chemistry itself (the antibody-enzyme-substrate system). It cannot rule out a probe binding nonspecifically to unrelated sequence or structure in the tissue. Because the sense probe has the same length, GC content, and labeling chemistry as the real antisense probe, it is a matched control for nonspecific probe binding in a way a no-probe control is not.

Related Techniques

ISH sits alongside other nucleic-acid detection and localization methods in a typical molecular/histology lab workflow: Southern blotting hybridizes a labeled probe to extracted, blotted DNA fragments rather than intact tissue, trading spatial information for the ability to resolve fragment size; ChIP-seq maps protein-DNA binding genome-wide rather than localizing a single target sequence in tissue. A cryostat is the standard instrument for producing the unfixed frozen sections many ISH protocols require.